SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pluristem Therapeutics
PSTI 8.720+0.2%Aug 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: xcentral15/12/2009 9:44:21 AM
   of 295
 
Pluristem Therapeutics to Present at the Center for Finance Education
Business Wire
Posted: 2009-05-12 08:30:00
Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that Mr. Zami Aberman, its President and CEO, and Mr. Yaky Yanay, its VP Finance and CFO, have been invited to be featured speakers at the Center for Finance Education Conference in Ramat Efal, Israel, to be held on May 24, 2009. Their presentation, titled "The Human Placenta as a Source for Cell Therapy, Transforming the Vision into Reality", will take place at the Beit-Homa Hall.

“From the auditoriums of educational centers, through the halls of medical centers and to the offices of Wall Street, the Pluristem team is constantly being invited to lecture about the Company’s clinical and financial developments,” stated Zami Aberman, Chairman, President and CEO of Pluristem. “We are proud to showcase the Company’s achievements in the research, clinical and business development areas.”
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext